Amdocs (NASDAQ:DOX) Issues FY 2024 Earnings Guidance

Amdocs (NASDAQ:DOX) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 6.320-6.560 for the period, compared to the consensus estimate of 6.500. The company issued revenue guidance of $5.0 billion-$5.1 billion, compared to the consensus revenue estimate of $5.0 billion. Amdocs also updated its Q3 2024 guidance to 1.570-1.630 EPS.

Amdocs Trading Up 1.0 %

NASDAQ:DOX traded up $0.86 during trading hours on Wednesday, reaching $85.91. The company’s stock had a trading volume of 743,750 shares, compared to its average volume of 660,316. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a market capitalization of $10.10 billion, a price-to-earnings ratio of 18.40, a PEG ratio of 1.36 and a beta of 0.70. The firm has a 50-day simple moving average of $88.69 and a 200-day simple moving average of $87.53. Amdocs has a 1 year low of $78.38 and a 1 year high of $99.75.

Amdocs (NASDAQ:DOX) last released its quarterly earnings data on Tuesday, February 6th. The technology company reported $1.56 EPS for the quarter, topping the consensus estimate of $1.40 by $0.16. The firm had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.24 billion. Amdocs had a return on equity of 17.79% and a net margin of 11.30%. The company’s quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.33 earnings per share. Research analysts expect that Amdocs will post 5.87 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages recently commented on DOX. Barclays lifted their target price on shares of Amdocs from $105.00 to $115.00 and gave the stock an overweight rating in a research note on Thursday, February 8th. StockNews.com cut shares of Amdocs from a strong-buy rating to a buy rating in a research report on Friday, March 15th. Finally, Citigroup increased their target price on shares of Amdocs from $96.00 to $104.00 and gave the stock a buy rating in a report on Wednesday, January 17th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of Buy and a consensus target price of $108.60.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.